OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00098559

Daqing Huake Co Ltd

Commodity ChemicalsVerified

Daqing Huake Co Ltd maintains a strong liquidity position, as evidenced by a current ratio of 8.09, indicating that the company holds significantly more current assets than current liabilities. The company operates with no long-term debt, and its debt-to-equity ratio is 0.0, suggesting a conservative capital structure with no leverage. However, the company reported negative free cash flow of -16,097,810 CNY, primarily due to capital expenditures of -46,995,610 CNY, which may indicate ongoing investment in operations or asset expansion. Profitability metrics for Daqing Huake Co Ltd are modest, with a return on equity (ROE) of 1.23% and a return on assets (ROA) of 1.12%. These figures are below the typical thresholds for high-performing chemical companies, suggesting that the company is generating limited returns relative to its equity and asset base. The company's operating income of 10,507,500 CNY and net income of 7,425,890 CNY reflect a narrow profit margin, which may be constrained by competitive pricing pressures or high production costs. The company's revenue is primarily derived from the domestic market, with limited exposure to overseas markets as disclosed in its business description. No specific segment or geographic breakdown is provided in the available data, but the lack of detailed revenue concentration data suggests that the company may not be highly diversified in terms of product lines or geographic reach. Looking ahead, the company's growth trajectory appears to be modest. The most recent actual revenue of 1,690,168,980 CNY is lower than the reported revenue of 1,845,908,210 CNY, indicating a potential decline in sales performance. While the company is investing in capital expenditures, the negative free cash flow suggests that these investments are not yet generating sufficient returns to offset the outflows. The absence of analyst estimates for future periods limits the ability to project near-term revenue growth with confidence. Risk factors for Daqing Huake Co Ltd are currently low, with no immediate liquidity or dilution flags detected in the risk assessment. The company's low debt load and strong current ratio provide a buffer against short-term financial stress. However, the negative free cash flow and modest profitability metrics may pose longer-term risks if not addressed through operational improvements or cost optimization. The company's dilution potential is also low, with no signs of recent or planned share issuance that could dilute existing shareholders. Recent events and disclosures for Daqing Huake Co Ltd are limited in the available data. The most recent actual earnings per share (EPS) of -0.02 CNY indicate a loss per share, which may be a concern for investors. The company's financial performance appears to be underperforming relative to expectations, and further analysis of its operational efficiency and cost structure may be warranted to identify areas for improvement.

30-day price · 000985-0.60 (-3.1%)
Low$18.08High$20.55Close$18.81As of15 May, 00:00 UTC
Profile
CompanyDaqing Huake Co Ltd
Ticker000985.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Daqing Huake Co Ltd is a China-based company engaged in the research, development, manufacture, and sales of chemical products, including C5 fraction products, C9 fraction products, petroleum resin products, and acetonitrile products.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Daqing Huake Co Ltd maintains a strong liquidity position, as evidenced by a current ratio of 8.09, indicating that the company holds significantly more current assets than current liabilities. The company operates with no long-term debt, and its debt-to-equity ratio is 0.0, suggesting a conservative capital structure with no leverage. However, the company reported negative free cash flow of -16,097,810 CNY, primarily due to capital expenditures of -46,995,610 CNY, which may indicate ongoing investment in operations or asset expansion. Profitability metrics for Daqing Huake Co Ltd are modest, with a return on equity (ROE) of 1.23% and a return on assets (ROA) of 1.12%. These figures are below the typical thresholds for high-performing chemical companies, suggesting that the company is generating limited returns relative to its equity and asset base. The company's operating income of 10,507,500 CNY and net income of 7,425,890 CNY reflect a narrow profit margin, which may be constrained by competitive pricing pressures or high production costs. The company's revenue is primarily derived from the domestic market, with limited exposure to overseas markets as disclosed in its business description. No specific segment or geographic breakdown is provided in the available data, but the lack of detailed revenue concentration data suggests that the company may not be highly diversified in terms of product lines or geographic reach. Looking ahead, the company's growth trajectory appears to be modest. The most recent actual revenue of 1,690,168,980 CNY is lower than the reported revenue of 1,845,908,210 CNY, indicating a potential decline in sales performance. While the company is investing in capital expenditures, the negative free cash flow suggests that these investments are not yet generating sufficient returns to offset the outflows. The absence of analyst estimates for future periods limits the ability to project near-term revenue growth with confidence. Risk factors for Daqing Huake Co Ltd are currently low, with no immediate liquidity or dilution flags detected in the risk assessment. The company's low debt load and strong current ratio provide a buffer against short-term financial stress. However, the negative free cash flow and modest profitability metrics may pose longer-term risks if not addressed through operational improvements or cost optimization. The company's dilution potential is also low, with no signs of recent or planned share issuance that could dilute existing shareholders. Recent events and disclosures for Daqing Huake Co Ltd are limited in the available data. The most recent actual earnings per share (EPS) of -0.02 CNY indicate a loss per share, which may be a concern for investors. The company's financial performance appears to be underperforming relative to expectations, and further analysis of its operational efficiency and cost structure may be warranted to identify areas for improvement.
Key takeaways
  • Daqing Huake Co Ltd maintains a strong liquidity position with a current ratio of 8.09 and no long-term debt.
  • The company's profitability is modest, with ROE and ROA of 1.23% and 1.12%, respectively.
  • Free cash flow is negative due to significant capital expenditures, indicating ongoing investment in operations.
  • Revenue is primarily generated in the domestic market, with limited geographic diversification.
  • Risk factors are currently low, with no immediate liquidity or dilution concerns.
  • Recent financial performance shows a loss per share, suggesting potential operational challenges.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.85B
Gross profit$92.4M
Operating income$10.5M
Net income$7.4M
R&D
SG&A
D&A
SBC
Operating cash flow$60.9M
CapEx-$47.0M
Free cash flow-$16.1M
Total assets$661.0M
Total liabilities$56.2M
Total equity$604.8M
Cash & equivalents
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$604.8M
Net cash
Current ratio8.1
Debt/Equity0.0
ROA1.1%
ROE1.2%
Cash conversion8.2%
CapEx/Revenue-2.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric000985Activity
Op margin0.6%0.4% medp25 -8.0% · p75 16.0%above median
Net margin0.4%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin5.0%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-2.5%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity0.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS-0.02 CNY
Last actual revenue1,690,168,980 CNY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 07:40 UTC#ad7db3b2
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 12:03 UTCJob: 01156573